(Q39877482)

15 September 2017

1 reference

title

Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy (English)

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

15 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

26 April 2023

author name string

S. B. Kapadia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417794

26 April 2023

J. R. Krause

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417794

26 April 2023

language of work or name

English

0 references

publication date

1 May 1978

1 reference

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

26 April 2023

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

26 April 2023

1 reference

15 September 2017

volume

41

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

1676-1679

1 reference

Cancer in the immunosuppressed patient

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197805%2941%3A5%3C1676%3A%3AAID-CNCR2820410505%3E3.0.CO%3B2-D

Acute myeloid leukaemia after treatment with cytostatic agents

21 January 2018

1

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia

26 April 2023

3

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Acute leukemia complicating metastatic breast cancer

26 April 2023

4

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Acute erythromegakaryocytic leukaemia after treatment with cytostatic agents

26 April 2023

6

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

26 April 2023

Epidemic acute leukemia

8

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Multiple primary malignant neoplasms. I. Introduction and presentation of data

26 April 2023

11

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Hodgkin's disease terminating in acute leukemia.

26 April 2023

12

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Occurrence of cancer in immune deficiencies

26 April 2023

13

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Chemical immunosuppression and human cancer

26 April 2023

14

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

26 April 2023

15

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Acute leukemia as a delayed consequence of cancer chemotherapy

26 April 2023

16

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Acute myeloid leukaemia after treatment with cytostatic agents

26 April 2023

17

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma)

26 April 2023

19

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

Lymphosarcoma terminating in acute myelogenous leukemia

26 April 2023

20

1 reference

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

https://api.crossref.org/works/10.1002/1097-0142(197805)41:5%3C1676::AID-CNCR2820410505%3E3.0.CO;2-D

26 April 2023

Identifiers

10.1002/1097-0142(197805)41:5<1676::AID-CNCR2820410505>3.0.CO;2-D

1 reference

15 September 2017

1 reference